drugset / Trial / NCT06493604
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
Timeline
- Start
- 2024-06-24
- Primary completion
- 2025-02-27
- Completion
- 2025-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reproxalap | Other / unclassified | 0.25 % | — |